Gabapentin Capsule
Product Images NDC 45865-194

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

194 (45865 194)

194 (45865 194)
This text appears to be related to a medication named Gabapentin capsules, which is a generic for Neurontin. The capsules contain 300mg of Gabapentin and come in a package size of 60 capsules. The medication may cause dizziness or drowsiness, and individuals are advised to avoid alcohol while taking it. The recommended dosage is indicated as a certain number of capsules to be taken multiple times daily. The manufacturer is SciGen Pharm Inc. from Hauppauge, NY.*
FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This text seems to describe a study comparing the effects of placebo and two different dosages of Gabapentin (1800 mg/day and 2400 mg/day) on pain scores over a 4-week period. The graph shows a decrease in mean pain score over the weeks of the study.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

Image-09 (Image 09)
This text provides information about daily doses of a medication, with values indicated for 600, 1200, and 1600 milligrams. The text also presents numerical values and symbols in a chart, possibly related to different doses of the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.